Financials in USD. Standardized financial statements.
A compact view of how Orthofix Medical Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $822.31M | $799.49M | $746.64M | $460.71M | $464.48M | $406.56M | $459.95M | $453.04M | $433.82M | $409.79M |
| Revenue Growth? | +2.9% | +7.1% | +62.1% | -0.8% | +14.2% | -11.6% | +1.5% | +4.4% | +5.9% | 0.0% |
| Cost of Revenue? | $270.61M | $253.61M | $260.37M | $123.54M | $114.91M | $101.89M | $100.61M | $96.63M | $93.04M | $87.85M |
| Gross Profit? | $551.71M | $545.88M | $486.27M | $337.17M | $349.56M | $304.67M | $359.35M | $356.41M | $340.79M | $321.94M |
| Gross Margin? | +67.1% | +68.3% | +65.1% | +73.2% | +75.3% | +74.9% | +78.1% | +78.7% | +78.6% | +78.6% |
| Operating Expenses? | $620.18M | $630.50M | $625.38M | $350.44M | $357.88M | $310.94M | $378.13M | $323.25M | $302.46M | $284.49M |
| Operating Income? | -$68.47M | -$84.62M | -$139.11M | -$13.27M | -$8.31M | -$6.27M | -$18.78M | $30.09M | $40.81M | $21.07M |
| EBITDA? | -$22.35M | -$34.18M | -$79.49M | $15.66M | $21.44M | $36.39M | $1.55M | $41.54M | $60.94M | $39.87M |
| Income Before Tax | -$90.81M | -$123.88M | -$148.68M | -$17.71M | -$13.49M | -$368,000 | -$27.05M | $22.89M | $36.39M | $19.02M |
| Income Tax Expense | $1.38M | $2.12M | $2.72M | $2.04M | $24.88M | -$2.88M | $1.41M | $9.07M | $29.10M | $15.53M |
| Net Income? | -$92.19M | -$126.00M | -$151.40M | -$19.75M | -$38.38M | $2.52M | -$28.46M | $13.81M | $6.22M | $3.06M |
| EPS? | $-2.28 | $-3.30 | $-4.12 | $-0.98 | $-1.95 | $0.13 | $-1.51 | $0.75 | $0.34 | $0.17 |
| Diluted EPS? | $-2.28 | $-3.30 | $-4.12 | $-0.98 | $-1.95 | $0.13 | $-1.51 | $0.73 | $0.34 | $0.17 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality